The company’s leading precision medicine software is now installed in more than 10% of U.S. hospitals.
SAN FRANCISCO, March 14, 2023 – InsightRX – which provides cloud-based precision medicine software to optimize treatment decisions – capped off another successful year in 2022. The company made remarkable progress in the development of its two core platforms, InsightRX Nova, an application designed to individualize drug dosing, and InsightRX Apollo, a real-time analytics application that aims to understand and improve drug performance across different patient populations. InsightRX’s ongoing innovation is evidence of its commitment to advancing precision medicine and improving patient outcomes. Read more >
